Patients With Brain Metastases From HER2-positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: TDM1|RADIATION: Brain Sequential RT
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle